FTC Pauses Challenge to Amgen’s $27.8 Billion Deal for Horizon Therapeutics
The Wall Street JournalThe move gives the agency time to weigh a settlement that would allow the deal to close with conditions.
The move gives the agency time to weigh a settlement that would allow the deal to close with conditions.
